
No. of Pages: 77 | Report Code: TIPRE00028644 | Category: Life Sciences
No. of Pages: 77 | Report Code: TIPRE00028644 | Category: Life Sciences
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Market Drivers
4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
4.2 Market Restraints
4.2.1 Side Effects of Botulinum Toxin
4.3 Market Opportunities
4.3.1 Rising Adoption of Aesthetic Procedure in Emerging Economies
4.4 Future Trends
4.4.1 Expanding Therapeutic Applications
4.5 Impact of Drivers and Restraints:
5.1 Overview
5.2 Botulinum Toxin Market Revenue (US$ Million), 2021–2031
6.1 Overview
6.2 Botulinum Toxin A
6.2.1 Overview
6.2.2 Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Botulinum Toxin B
6.3.1 Overview
6.3.2 Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
7.1 Overview
7.2 Medical
7.2.1 Overview
7.2.2 Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 North America Botulinum Toxin Market Breakdown, by Medical
7.3 Aesthetic
7.3.1 Overview
7.3.2 Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 North America Botulinum Toxin Market Breakdown, by Aesthetic
8.1 Overview
8.2 Specialty and Dermatology Clinics
8.2.1 Overview
8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Hospitals and Clinics
8.3.1 Overview
8.3.2 Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1 North America: Botulinum Toxin Market
9.1.1 North America: Botulinum Toxin Market – Revenue and Forecast Analysis – by Country
9.1.1.1 United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.1.3 United States: Botulinum Toxin Market Breakdown, by Product
9.1.1.1.4 United States: Botulinum Toxin Market Breakdown, by Application
9.1.1.1.4.1 United States: Botulinum Toxin Market Breakdown, by Medical
9.1.1.1.4.2 United States: Botulinum Toxin Market Breakdown, by Aesthetic
9.1.1.1.5 United States: Botulinum Toxin Market Breakdown, by End User
9.1.1.2 Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.2.3 Canada: Botulinum Toxin Market Breakdown, by Product
9.1.1.2.4 Canada: Botulinum Toxin Market Breakdown, by Application
9.1.1.2.4.1 Canada: Botulinum Toxin Market Breakdown, by Medical
9.1.1.2.4.2 Canada: Botulinum Toxin Market Breakdown, by Aesthetic
9.1.1.2.5 Canada: Botulinum Toxin Market Breakdown, by End User
9.1.1.3 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
9.1.1.3.3 Mexico: Botulinum Toxin Market Breakdown, by Product
9.1.1.3.4 Mexico: Botulinum Toxin Market Breakdown, by Application
9.1.1.3.4.1 Mexico: Botulinum Toxin Market Breakdown, by Medical
9.1.1.3.4.2 Mexico: Botulinum Toxin Market Breakdown, by Aesthetic
9.1.1.3.5 Mexico: Botulinum Toxin Market Breakdown, by End User
10.1 Merz Pharma GmbH & Co KGaA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 AbbVie Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Ipsen SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Evolus Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Aquavit
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Revance Therapeutics Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Medytox Inc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Galderma SA
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Hugel Inc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Lanzhou Institute of Biological Products Co Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11.1 About The Insight Partners
Table 1. Botulinum Toxin Market Segmentation
Table 2. North America Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical
Table 3. North America Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic
Table 4. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 5. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 6. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical
Table 7. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic
Table 8. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 9. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 10. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 11. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical
Table 12. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic
Table 13. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 15. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 16. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical
Table 17. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic
Table 18. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 19. Glossary of Terms
Figure 1. Botulinum Toxin Market Segmentation, by Country
Figure 2. Botulinum Toxin Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021–2031
Figure 5. Botulinum Toxin Market Share (%) – by Product (2023 and 2031)
Figure 6. Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Botulinum Toxin Market Share (%) – by Application (2023 and 2031)
Figure 9. Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Botulinum Toxin Market Share (%) – by End User (2023 and 2031)
Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. North America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million)
Figure 16. North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 17. United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)